PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-22

  1. 9,839 Posts.
    lightbulb Created with Sketch. 1258
    Click link in todays ASX Qtr under Global Conference

    He is talking complete BS but curious why do it now?

    I can only assume he is referencing 1 x weekly being less effective than placebo under certain metrics. Placebo variation is wide and known. 2mg x 2 weekly is gold.

    No SAE recorded in 1200 patients treated during clinical and non clinical programs

    Look at my post on Humira - SAE include observations of cancer and death
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.